Company Profile
Relmada Stock Price, News & Analysis
- Ticker:
- RLMD
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- United States
Stock performance
6.21 USD (0.00%)
Close
Last updated: July 15, 2026 at 00:00
672.97M USD
Market cap
Why the stock is moving
RLMD is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Relmada is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Relmada is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Relmada follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Relmada sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
- 02
Alnylam to Webcast Conference Call Discussing Second Quarter 2026 Financial Results
ALNY · Source: Alnylam Pharmaceuticals, Inc.
- 03
- 04
Acadia Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 4, 2026
ACAD · Source: ACADIA Pharmaceuticals Inc.
- 05
GSK completes acquisition of Nuvalent, Inc.
GSK · Source: GSK plc
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Relmada (RLMD)?
Relmada (RLMD) most recently closed at 6.21 USD, a 0.00% move versus the previous session.
What is the market cap of Relmada (RLMD)?
Relmada currently has a market capitalization of 672.97M USD on BioPharmSignal.
What does Relmada do?
Relmada is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is RLMD stock listed?
Relmada (RLMD) is associated with NASDAQ, United States, Biotechnology.
What is Relmada?
Relmada is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Relmada targeting with Relmada?
Relmada is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.